Cargando…
Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
Based on their unique advantages, increasing interest has been shown in the use of aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy. Recently, the development of aptamer-conjugated nanomaterials has offered new therapeutic opportunities for cancer treatment...
Autores principales: | Liu, Qiaoling, Jin, Chen, Wang, Yanyue, Fang, Xiaohong, Zhang, Xiaobing, Chen, Zhuo, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880215/ https://www.ncbi.nlm.nih.gov/pubmed/29619132 http://dx.doi.org/10.1038/am.2014.12 |
Ejemplares similares
-
Recent progress of aptamer‒drug conjugates in cancer therapy
por: He, Jiaxuan, et al.
Publicado: (2023) -
Aptamer Nanomaterials for Ovarian Cancer Target Theranostics
por: Zhao, Jing, et al.
Publicado: (2022) -
Applications of Aptamer-Bound Nanomaterials in Cancer Therapy
por: Zhu, Liangxi, et al.
Publicado: (2021) -
Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016) -
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
por: Li, Yongshu, et al.
Publicado: (2022)